Skip to content
Open access

Proteomic markers linking anxiety phenotypes to Alzheimers disease risk: a multi-analyte proteomic analysis

Sep 2026 · medRxiv · 0 citations
Medicine

TL;DR

Distinct anxiety phenotypes map onto dissociable plasma proteomic profiling, converging on a shared neurodegeneration axis reflecting neuronal injury, while diverging across neuroimmune, vascular, and proteostatic domains.

Read PDF

Similar papers

Open access Jul 2026

Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis

The potential of plasma proteomic clocks in detecting AD‐related phenotypes and co‐morbidities possibly constitute confounding factors, compromising the performance of proteomic aging models is illustrated.

Cindy David Sarmento, G. Drouard, T. Saari et al. · 1 citation
Open access Sep 2026

Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

In CSF-confirmed participants, age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181, which suggests that plasma biomarkers are influenced primarily by age and genetic background rather than by metabolic factors in this cohort.

Carolin I. Kurz, Marleen Taute, Paulina Tegethoff et al. · 0 citations
Aug 2026

Proteomic Features and Association Analysis of Late-Onset Depression Based on Behavioral Factorial Analysis and Proteomics

Late-onset depression (LOD) is a common subtype of depression in the elderly, characterized by high disability and recurrence rates, along with poorly understood biological correlates, posing a serious threat to the health of the aging population; moreover, the molecular correlates and diagnostic targets for LOD rema...

Yu-Qi Yan, Hanfang Xu, Tian-Ge Zhang et al. · 0 citations
Open access Aug 2026

Alzheimers disease blood biomarkers reveal proteomic modules of disease progression

Routine and accessible plasma measures can be leveraged to recover reproducible, biologically distinct progression modules that improve characterization of heterogeneous AD and have practical value for risk stratification, trial enrichment, or treatment monitoring.

R. R. Butler, M. Brown, A. Weber et al. · 1 citation
Open access Sep 2026

Insomnia symptoms and stress exposure interact in relation to Alzheimer’s disease biomarkers

It is suggested that chronic stress and sleep disturbances exhibit an interactive relationship in their associations with AD pathology, and the need for further research into interactive effects of multiple modifiable risk factors in the development of AD is highlighted.

J. Holleman, I. Kåreholt, Manasa Shanta Näsholm et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.